Cardiff Oncology, Inc.

Q2 2020 13F Holders

Symbol
CRDF
CUSIP
14147L108
Type
Equity
Class
COM
Num filings
32
Total reported value, excl. options
$25.0 M
Manager Report Date Value ($000) Shares Option Type